GSK Reported Probing 1,000 Workers, Firing 150 In China Bribery Scandal
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline reportedly has fingered about 1,000 employees for possible involvement in the compliance scandal in China that caused turmoil in the drug-making industry last summer.